Etomidate vs propofol in coronary heart disease patients undergoing major noncardiac surgery:A randomized clinical trial  

作　　者：Zhong-Liang Dai Xing-Tao Cai Wen-Li Gao Miao Lin Juan Lin Yuan-Xu Jiang Xin Jiang 

机构地区：[1]Department of Anesthesiology,The First Affiliated Hospital of Southern University,The Second Clinical Medical College of Jinan University,Shenzhen People’s Hospital,Shenzhen 518020,Guangdong Province,China [2]Department of Geriatrics,The First Affiliated Hospital of Southern University,The Second Clinical Medical College of Jinan University,Shenzhen People’s Hospital,Shenzhen 518020,Guangdong Province,China

出　　处：《World Journal of Clinical Cases》2021年第6期1293-1303,共11页世界临床病例杂志

基　　金：Supported by Shenzhen Municipal Science and Technology Foundation,No.JCYJ20170307100314152;Shenzhen Health Research Fund,No.SZLY2018011, No.SZXJ2017029;Guangdong Medical Research Fund,No.A2018008 and No.A2019382;Scientific Research Fund of Shenzhen People’s Hospital,No.SYLY201706;and Shenzhen Key Medical Discipline Construction Fund,No.SZXK012.

摘　　要：BACKGROUND The ideal depth of general anesthesia should achieve the required levels of hypnosis,analgesia,and muscle relaxation while minimizing physiologic responses to awareness.The choice of anesthetic strategy in patients with coronary heart disease(CHD)undergoing major noncardiac surgery is becoming an increasingly important issue as the population ages.This is because general anesthesia is associated with a risk of perioperative cardiac complications and death,and this risk is much higher in people with CHD.AIM To compare hemodynamic function and cardiovascular event rate between etomidate-and propofol-based anesthesia in patients with CHD.METHODS This prospective study enrolled consecutive patients(American Society of Anesthesiologists grade II/III)with stable CHD(New York Heart Association class I/II)undergoing major noncardiac surgery.The patients were randomly allocated to receive either etomidate/remifentanil-based or propofol/remifentanil-based general anesthesia.Randomization was performed using a computer-generated random number table and sequentially numbered,opaque,sealed envelopes.Concealment was maintained until the patient had arrived in the operating theater,at which point the consulting anesthetist opened the envelope.All patients,data collectors,and data analyzers were blinded to the type of anesthesia used.The primary endpoints were the occurrence of cardiovascular events(bradycardia,tachycardia,hypotension,ST-T segment changes,and ventricular premature beats)during anesthesia and cardiac troponin I level at 24 h.The secondary endpoints were hemodynamic parameters,bispectral index,and use of vasopressors during anesthesia.RESULTS The final analysis included 40 patients in each of the propofol and etomidate groups.The incidences of bradycardia,hypotension,ST-T segment changes,and ventricular premature beats during anesthesia were significantly higher in the propofol group than in the etomidate group(P<0.05 for all).The incidence of tachycardia was similar between the two groups.Cardiac tropo

关 键 词：ETOMIDATE PROPOFOL General anesthesia Coronary heart disease HEMODYNAMIC Cardiovascular events 

分 类 号：R541.4[医药卫生—心血管疾病]